Compare · OHI vs VTR
OHI vs VTR
Side-by-side comparison of Omega Healthcare Investors Inc. (OHI) and Ventas Inc. (VTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OHI and VTR operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- VTR is the larger of the two at $48.13B, about 3.4x OHI ($14.23B).
- VTR has been more active in the news (3 items in the past 4 weeks vs 2 for OHI).
- Both have 25 recent analyst ratings on file.
- Company
- Omega Healthcare Investors Inc.
- Ventas Inc.
- Price
- -
- -
- Market cap
- $14.23B
- $48.13B
- 1M return
- -
- -6.27%
- 1Y return
- -
- +38.82%
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NYSE
- NYSE
- IPO
- 1992
- News (4w)
- 2
- 3
- Recent ratings
- 25
- 25
Omega Healthcare Investors Inc.
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Ventas Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Latest OHI
- Director Egbuonu-Davis Lisa gifted 5,131 shares, decreasing direct ownership by 23% to 17,301 units (SEC Form 4)
- New insider Golem Lucas M. claimed ownership of 1,685 shares (SEC Form 3)
- SEC Form 10-Q filed by Omega Healthcare Investors Inc.
- Omega Healthcare Investors Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Omega Reports Second Quarter 2026 Results and Recent Developments
- Omega Announces Increase in Quarterly Dividend
- Barclays initiated coverage on Omega Health with a new price target
- Omega Announces Second Quarter Earnings Release Date and Conference Call
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Stephenson Robert O
- SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Pickett C Taylor
Latest VTR
- Ventas Releases 2025-2026 Corporate Sustainability Report
- EVP OM&R-Ventas/Pres&CEO-LHS Wattula Andy was granted 15,008 shares (SEC Form 4)
- SEC Form 3 filed by new insider Wattula Andy
- SEC Form 10-Q filed by Ventas Inc.
- Ventas Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ventas Reports 2026 Second Quarter Results
- Amendment: SEC Form SCHEDULE 13G/A filed by Ventas Inc.
- Director Smith Maurice S was granted 128 shares, increasing direct ownership by 0.41% to 31,311 units (SEC Form 4)
- Director Embler Michael J was granted 72 shares, increasing direct ownership by 0.37% to 19,274 units (SEC Form 4)
- Director Nader Marguerite M was granted 72 shares, increasing direct ownership by 0.31% to 23,544 units (SEC Form 4)